Medical Technology Enterprise Consortium

What Medical Technology Enterprise Consortium does

Medical Technology Enterprise Consortium (MTEC) is a 501(c)(3) nonprofit biomedical technology consortium that operates under an Other Transaction Agreement (OTA) awarded by the U.S. Department of Defense. Headquartered in Frederick, Maryland with a 51-100 person team, MTEC serves as an intermediary that administers federal funding solicitations from agencies including the Defense Health Agency (DHA), Defense Threat Reduction Agency (DTRA), and the U.S. Army Medical Research and Materiel Command (USAMRMC). Its primary customers are federal agencies seeking to accelerate medical technology development for military and dual-use civilian applications, while its 750+ member organizations across 20+ countries — including small and large businesses, academic institutions, and nonprofits — are the supplier base that competes for awards through the consortium.

MTEC's core offering is the OTA funding platform, supported by the BIDS (Biomedical Information and Data System) proposal submission and tracking platform, a Technology Showcase of member pipelines (150 products), and proposal preparation resources including TRL/KRL checklists and IP training. The consortium has facilitated $1.5B in federal funding, generated $1.2B in follow-on funding, and awarded 384 projects over a decade of operation, with member-developed products spanning manufactured red blood cells, AI-driven wearables for early illness detection, non-invasive intracranial pressure monitoring, and expeditionary drug infusion systems. MTEC supplements its federal funding administration with consortium membership fees and event-driven engagement including the Annual Membership Meeting, partnering forums during JPM Healthcare Week, and the Defense Medical Innovation Summit.

The business model combines federal funding administration (with management fees and indirect cost recovery on pass-through awards), recurring consortium membership dues, and event-driven engagement with healthcare investors and academic partners. MTEC is governed by a Board of Directors representing industry, small business, and member stakeholders, with a newly launched MTEC Academic Advisory Council (MAAC) deepening academic integration. Strategic recent moves include expanded partnerships with BARDA and ASPR for civilian biodefense and the August 2025 launch of MAAC to broaden the academic pipeline for military medical innovation.

Name

Medical Technology Enterprise Consortium

Legal name

Medical Technology Enterprise Consortium

Website

https://mtec-sc.org

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

MTEC is a 501(c)(3) nonprofit consortium that administers U.S. Department of Defense medical technology funding through an Other Transaction Agreement, connecting federal agencies with 750+ member organizations across 20+ countries to accelerate military and civilian health innovation.

Ownership category

akta.pro rank

Headquarters

HQ city

Summerville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Federal Funding Administration: MTEC facilitates federal funding from DoD and other agencies through their OTA consortium structure. They administer project awards, manage funding disbursements, and track follow-on funding outcomes. The IRS recognizes MTEC as a 501(c)(3) charitable organization.
2. Consortium Membership: Revenue derived from consortium membership fees paid by member organizations (small and large businesses, academic institutions, nonprofits) who gain access to funding opportunities, networking, and MTEC's ecosystem of government partners and innovators.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

MTEC is a nonprofit biomedical technology consortium that facilitates federal funding from the U.S. Department of Defense and other agencies to member organizations developing innovative medical technologies for military and civilian health. Its core offering is an Other Transaction Agreement (OTA) consortium structure that provides a flexible contracting vehicle reducing administrative burden and accelerating time-to-award compared with traditional federal procurement. The consortium operates the BIDS proposal submission platform, provides proposal preparation resources and compliance guidance, and curates a Technology Showcase of member pipeline products.

Product overview

MTEC is a nonprofit consortium operating under a government-awarded Other Transaction Agreement (OTA) that advances the rapid deployment of innovative medical technologies for military and civilian health. The core offering is the OTA funding platform enabling efficient access to government funding with reduced administrative burden. Key supporting services include the BIDS (Biomedical Information and Data System) for proposal submission and tracking, a Technology Showcase displaying 150+ products in pipeline from 750+ member organizations, and annual partnering forum events. Proposal preparation resources, intellectual property training, and TRL/KRL checklists support members through the funding process. Member organizations contribute specialized products including RTI International's open-access research publications and epidemiological dashboards, Vivonics' non-invasive brain monitoring devices and contactless vital-sign platforms, and Lynntech's expeditionary drug infusion pumps and hypoxia training systems. The consortium has facilitated $1.5B in federal funding with $1.2B follow-on funding across 384 awarded projects.

Differentiator

Problem solved

Functional benefit

Products and services

• MTEC OTA Funding Platform
• BIDS (Biomedical Information and Data System)
• Technology Showcase
• Partnering Forum Events
• Proposal Preparation Resources
• MTEC Annual Reports

Quantifiable outcome

• $1.5B in federal funding facilitated through OTA consortium
• +4 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability14 records

Feature3 records

Partnerships

Six partnerships are on record, tiered key and core.

• Biomedical Advanced Research and Development Authority (BARDA)keyStrategic or Co-development Partner · 10 December 2025BARDA collaborates with MTEC and DHA on the Platelet & Platelet-like Products State of Technology Meeting, combining BARDA's radiological and nuclear medical countermeasures expertise with military health priorities.
• Administration for Strategic Preparedness and ResponsekeyStrategic or Co-development Partner · 10 December 2025ASPR's BARDA division co-hosts events with MTEC focused on advancing medical countermeasures and expanding domestic manufacturing capacity for military medical supplies.
• MTEC Academic Advisory Council (MAAC)keyStrategic or Co-development Partner · 5 August 2025Academic advisory council launched to supercharge academia's role in military medical innovation. Includes representatives from University of Utah, MGB/Home Base, University of Colorado, and University of Pittsburgh.
• Defense Health Agency (DHA)coreStrategic or Co-development PartnerPrimary federal agency partner providing funding for military medical technology projects through MTEC's OTA consortium. DHA sponsors initiatives including blood product development, pharmacogenomics testing, expeditionary medicine, and PTSD prediction models.
• Defense Threat Reduction Agency (DTRA)coreStrategic or Co-development PartnerDTRA partners with MTEC for biodefense readiness initiatives including on-demand biologics development, automated threat detection, and alternative testing methods for medical countermeasures in high containment environments.
• U.S. Army Medical Research and Materiel Command (USAMRMC)coreStrategic or Co-development PartnerKey government partner whose experts developed Knowledge Readiness Levels (KRLs) to assist in making investment decisions across health research lines. USAMRMC provides foundational research oversight for MTEC programs.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Medical Countermeasure Consortium (MCDC): Another DoD-backed OTA consortium that funds development of medical countermeasures for chemical, biological, and radiological threats. Operates the same consortium model as MTEC and competes for member participation and federal sponsor mindshare.
• CIMIT (Center for Integration of Medicine and Innovative Technology): Nonprofit consortium that accelerates medical technology innovation by linking academic, industry, and clinical partners. Shares MTEC's facilitator/ecosystem-builder model for advancing medtech from concept to clinical use.
• BIO (Biotechnology Innovation Organization): Largest biotech trade association with a member-based, dues-funded model supporting industry access to capital, advocacy, and partnering events. Comparable to MTEC as a member-serving industry organization, though broader in scope and focused on commercial biotech.
• AdvaMed: Medical device industry trade association connecting manufacturers, innovators, and government stakeholders. Operates a similar member-consortium model and represents an analogous stakeholder position in the medical technology ecosystem.

Broad incumbents

• BARDA (Biomedical Advanced Research and Development Authority): HHS authority that funds development and procurement of medical countermeasures. Already an active MTEC partner (Platelet & Platelet-like Products SOT), BARDA is a much larger federal funding entity that intersects MTEC's mission space.
• CEPI (Coalition for Epidemic Preparedness Innovations): Global consortium funding vaccine and biologic development against epidemic threats. Comparable to MTEC in its public-private consortium model, member-driven governance, and facilitation of milestone-based funding for biomedical innovation.
• BARDA DRIVe (Division of Research, Innovation, and Ventures): BARDA division that funds breakthrough health security technologies through non-traditional mechanisms. Operates in adjacent funding territory to MTEC and represents an alternative pathway for medical technology innovators seeking federal R&D dollars.

Emerging players

• ARMI / BioFabUSA: Nonprofit consortium building the regenerative manufacturing industry through public-private partnerships with DoD-affiliated agencies. Comparable consortium-driven funding-and-ecosystem model, though focused on tissue engineering rather than general medical technology.

Others

• FedTech: Startup studio that helps technology companies commercialize federally funded R&D into the private market. Adjacent to MTEC on the federal-to-commercial pathway for medtech and dual-use technologies emerging from MTEC's portfolio.
• Larta Institute: Nonprofit innovation hub that connects emerging companies with government funding (e.g., SBIR/STTR) and commercial capital. Plays a comparable ecosystem-builder role for federally backed innovation, particularly relevant to MTEC's SMB member base.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/medical-technology-enterprise-consortium
• Xx.com/MTEC_SC
• Facebookfacebook.com/MTEC-1043610495736672

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles21 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments12 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medical Technology Enterprise Consortium